Stay updated on Mirvetuximab Soravtansine Clinical Trial
Sign up to get notified when there's something new on the Mirvetuximab Soravtansine Clinical Trial page.

Latest updates to the Mirvetuximab Soravtansine Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No visible changes to the Study Details page or its content.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedThe page now shows a site revision of v3.4.2. The previous revision v3.4.1 has been removed.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1; no substantive content changes observed on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a 'Show glossary' option and updated QC-related labels to display 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the older label variations 'Last Update Submitted that met QC Criteria', the lowercase 'No FEAR Act data', and the previous 'Revision: v3.3.4'; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check79 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. No study content or core functionality appears to be changed.SummaryDifference0.0%

Stay in the know with updates to Mirvetuximab Soravtansine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mirvetuximab Soravtansine Clinical Trial page.